Interleukin-18-induced atherosclerosis involves CD36 and NF-κB crosstalk in Apo E-/- mice

Journal of Cardiology

Volumn 66, Issue 1, 2015, Pages 28-35

  Bhat, Owais Mohammad ^a   Kumar, P Uday ^b   Giridharan, N V ^c   Kaul, Deepak ^a   Kumar, M J Mahesh ^d   Dhawan, Veena ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b NATIONAL INSTITUTE OF NUTRITION   (India)

^c AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^d CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Atherosclerosis; CD36; Liver X receptor alpha; Nuclear factor kappa B; Recombinant interleukin 18

Indexed keywords

APOLIPOPROTEIN E; CD36 ANTIGEN; CHOLESTEROL; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR ALPHA; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PYRROLIDINE DITHIOCARBAMATE; RECOMBINANT INTERLEUKIN 18; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; THIOCARBAMIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAPILLARY ENDOTHELIAL CELL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HEART MUSCLE CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE SECTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CORONARY ARTERY DISEASE; DISEASE MODEL; GENETICS; IMMUNOLOGY; INBRED MOUSE STRAIN; INFLAMMATION; METABOLISM;

ANIMALS; ANTIGENS, CD36; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; INFLAMMATION; INTERLEUKIN-18; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED STRAINS; PYRROLIDINES; RNA, MESSENGER; THIOCARBAMATES;

EID: 84930886746     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.10.012     Document Type: Article

References (34)

1. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
2. Repa J.J., Mangelsdorf D.J. The liver X receptor gene team: potential new players in atherosclerosis. Nat Med 2002, 8:1243-1248.
3. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., Watson A.D., Lusis A.J. Atherosclerosis: basic mechanisms: oxidation, inflammation and genetics. Circulation 1995, 91:2488-2496.
4. Raffetto J.D., Khalil R.A. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008, 75:346-359.
5. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
6. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994, 14:133-140.
7. Mallat Z., Corbaz A., Scoazec A., Besnard S., Leseche G., Chvatchko Y., Tedgui A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001, 104:1598-1603.
8. Mallat Z., Corbaz A., Scoazec A., Graber P., Alouani S., Esposito B., Humbert Y., Chvatchko Y., Tedgui A. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001, 89:e41-e45.
9. Hoshino K., Tsutsui H., Kawai T., Takeda K., Nakanishi K., Takeda Y., Akira S. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J Immunol 1999, 162:5041-5044.
10. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M., Maeda N. Generation of mice carrying a mutant apolipoprotein-E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 1992, 89:4471-4475.
11. Whitman S.C., Ravisankar P., Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E (-/-) mice through release of interferon-gamma. Circ Res 2002, 90:E34-E38.
12. Cuzzocrea S., Chatterjee P.K., Mazzon E., Dugo L., Serraino I., Britti D., Mazzullo G., Caputi A.P., Thiemermann C. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 2002, 135:496-510.
13. Whitman S.C., Ravisankar P., Elam H., Daugherty A. Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice. Am J Pathol 2000, 157:1819-1824.
14. Friedwald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
15. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using Real-Time Quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods 2001, 25:402-408.
16. Tenger C., Sundborger A., Jawien J., Zhou X. IL-18 accelerates atherosclerosis accompanied by elevation of IFN-γ and CXCL16 expression independently of T cells. Arterioscler Thromb Vasc Biol 2005, 25:791-796.
17. Silverstein R.L. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve Clin J Med 2009, 76:S27-S30.
18. Guy E., Kuchibhotla S., Silverstein R., Febbraio M. Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36o/Apo Eo mice. Atherosclerosis 2007, 192:123-130.
19. Gerdes N., Sukhova G.K., Libby P., Reynolds R.S., Young J.I., Schonbeck U. Expression of IL-18 and functional IL-18 receptor on vascular endothelial cells, smooth muscle cells and macrophages: implications for atherogenesis. J Exp Med 2002, 195:245-257.
20. Quiding-Jarbank M., Smith D.A., Bancroft G.J. Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun 2001, 69:5661-5670.
21. Elhage R., Jawien J., Rudling M., Ljunggren H.G., Takeda K., Akira S., Bayard F., Hansson G.K. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003, 59:234-240.
22. Nakamura A., Shikata K., Hiramatsu M., Nakatou T., Kitamura T., Wada J., Itoshima T., Makino H. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 2005, 28:2890-2895.
23. Hulthe J., McPheat W., Samnegard A., Tornvall P., Hamsten A., Eriksson P. Plasma interleukin-18 concentration is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis 2006, 188:450-454.
24. Morel J.C., Park C.C., Woods J.M., Koch A.E. A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidyl-inositol (PI) 3-kinase dependent signal transduction pathways. J Biol Chem 2001, 276:37069-37075.
25. Sahar S., Dwarakanath R.S., Reddy M.A., Lanting L., Todorov I., Natarajan R. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells. A novel cross-talk in the pathogenesis of atherosclerosis. Circ Res 2005, 96:1064-1071.
26. Matsumoto S., Tsuji-Takayama K., Aizawa Y., Koide K., Takeuchi M., Ohta T., Kurimoto M. Interleukin-18 activates NF-KB in murine T helper type 1 cells. Biochem Biophys Res Commun 1997, 234:454-457.
27. Bond M., Chase A.J., Baker A.H., Newby A.C. Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 2001, 50:556-565.
28. Wu K.I., Schmid-Schönbein G.W. Nuclear factor kappa B and matrix metalloproteinase induced receptor cleavage in the spontaneously hypertensive rat. Hypertension 2011, 57:261-268.
29. Venkateswaran A., Laffitte B.A., Joseph S.B., Mak P.A., Wilpitz D.C., Edwards P.A., Tontonoz P. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci USA 2000, 97:12097-12102.
30. Schaefer E.J., Gregg R.E., Ghiselli G., Forte T.M., Ordovas J.M., Zech L.A., Brewer H.B. Familial apolipoprotein E deficiency. J Clin Invest 1986, 78:1206-1219.
31. Netea M.G., Kullberg B.J., Verschueren I., Van Der Meer J.W. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur J Immunol 2000, 30:3057-3060.
32. Jablonska E., Jablonski J. Effect of IL-18 on the release of IL-6 and its soluble receptors: sIL-6Ralpha and sgp130 by human neutrophils. Immunol Invest 2002, 31:159-167.
33. Mariappan N., Elks C.M., Sriramula S., Guggilam A., Liu Z., Borkhsenious O., Francis J. NF-κB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res 2010, 85:473-483.
34. Jawień J., Gajda M., Mateuszuk Ł., Olszanecki R., Jakubowski A., Szlachcic A., Korabiowska M., Korbut R. Inhibition of nuclear factor-κB attenuates atherosclerosis in Apo E/LDLR - double knockout mice. J Physiol Pharmacol 2005, 56:483-489.